
Transplantation Market by Product (Immunosuppressive Drugs, Tissue Products), Application (Organ Transplantation, Tissue Transplantation), End Use - Global Forecast 2024-2030
Description
Transplantation Market by Product (Immunosuppressive Drugs, Tissue Products), Application (Organ Transplantation, Tissue Transplantation), End Use - Global Forecast 2024-2030
The Transplantation Market size was estimated at USD 28.67 billion in 2023 and expected to reach USD 31.09 billion in 2024, at a CAGR 8.53% to reach USD 50.86 billion by 2030.
Global Transplantation Market
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Transplantation Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Transplantation Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Transplantation Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Arthrex, Inc., Australian Red Cross Lifeblood, BioLife Solutions Inc., Dr. Franz Kohler Chemie GmbH, LifeCell International Pvt. Ltd., Mid-America Transplant, Novartis AG, Sanofi S.A., Stryker Corporation, Terumo Corporation, Teva Pharmaceutical Industries Ltd, TransMedics, Inc., Veloxis Pharmaceuticals, and Zimmer Biomet.
Market Segmentation & Coverage
This research report categorizes the Transplantation Market to forecast the revenues and analyze trends in each of the following sub-markets:
Product
Immunosuppressive Drugs
Tissue Products
Application
Organ Transplantation
Tissue Transplantation
End Use
Hospitals
Transplant Centers
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Transplantation Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Transplantation Market?
3. What are the technology trends and regulatory frameworks in the Transplantation Market?
4. What is the market share of the leading vendors in the Transplantation Market?
5. Which modes and strategic moves are suitable for entering the Transplantation Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
195 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Transplantation Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing prevalence of chronic diseases
- 5.1.1.2. Growing awareness about organ donation and registration
- 5.1.1.3. Rising development of tissue banks
- 5.1.2. Restraints
- 5.1.2.1. Shortage of organ donation for treatment of organ failure
- 5.1.3. Opportunities
- 5.1.3.1. Rising technological advancement in transplant surgeries
- 5.1.3.2. Growing active initiatives by government and non-government organizations
- 5.1.4. Challenges
- 5.1.4.1. Growing ethical and cultural issues associated with transplantations
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Transplantation Market, by Product
- 6.1. Introduction
- 6.2. Immunosuppressive Drugs
- 6.3. Tissue Products
- 7. Transplantation Market, by Application
- 7.1. Introduction
- 7.2. Organ Transplantation
- 7.3. Tissue Transplantation
- 8. Transplantation Market, by End Use
- 8.1. Introduction
- 8.2. Hospitals
- 8.3. Transplant Centers
- 9. Americas Transplantation Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Transplantation Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
- 11. Europe, Middle East & Africa Transplantation Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. AbbVie Inc.
- 13.1.2. Arthrex, Inc.
- 13.1.3. Australian Red Cross Lifeblood
- 13.1.4. BioLife Solutions Inc.
- 13.1.5. Dr. Franz Kohler Chemie GmbH
- 13.1.6. LifeCell International Pvt. Ltd.
- 13.1.7. Mid-America Transplant
- 13.1.8. Novartis AG
- 13.1.9. Sanofi S.A.
- 13.1.10. Stryker Corporation
- 13.1.11. Terumo Corporation
- 13.1.12. Teva Pharmaceutical Industries Ltd
- 13.1.13. TransMedics, Inc.
- 13.1.14. Veloxis Pharmaceuticals
- 13.1.15. Zimmer Biomet
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
- FIGURE 1. TRANSPLANTATION MARKET RESEARCH PROCESS
- FIGURE 2. TRANSPLANTATION MARKET SIZE, 2023 VS 2030
- FIGURE 3. TRANSPLANTATION MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. TRANSPLANTATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. TRANSPLANTATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. TRANSPLANTATION MARKET DYNAMICS
- FIGURE 7. TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 8. TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 10. TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. TRANSPLANTATION MARKET SIZE, BY END USE, 2023 VS 2030 (%)
- FIGURE 12. TRANSPLANTATION MARKET SIZE, BY END USE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES TRANSPLANTATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES TRANSPLANTATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. TRANSPLANTATION MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 22. TRANSPLANTATION MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.